Genprex, Inc. Email Format

Biotechnology ResearchTexas, United States11-50 Employees

Genprex, Inc. is a clinical-stage biotechnology company based in Austin, Texas, focused on developing gene therapies for cancer and diabetes. It seeks to deliver disease-fighting genes through a proprietary, non-viral delivery system designed for systemic administration, aiming to reach patient populations with limited treatment options. Its oncology program centers on REQORSA for non-small cell lung cancer and small cell lung cancer, currently evaluated in multiple clinical trials with FDA Fast Track designations, and the company partners with academic and research institutions to advance its pipeline. 

In diabetes, Genprex pursues a gene-therapy approach that delivers Pdx1 and MafA to the pancreas via an endoscopic infusion, with GPX-002 and GPX-003 targeted at Type 1 and Type 2 diabetes, respectively. Recent activity includes participation in BIO Europe Spring 2026 and a collaboration with ALK Positive to advance preclinical studies.

Get verified Genprex, Inc. emails free

Company overview Employee directory